AT & S Austria Technologie & Systemtechnik (ATS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Nov, 2025Executive summary
Achieved strong operating performance in a challenging environment, with significant progress in cost optimization and customer diversification.
Second-best result in company history for sales and EBITDA, with a major positive impact from the sale of the Ansan plant.
Major investments in Kulim (Malaysia) and Leoben (Austria) are on track, with high-volume production started and further customer diversification underway.
Efficiency program delivered €120 million in cost savings, with an additional €130 million targeted for the next year.
Equity ratio increased and leverage reduced; no dividend proposed to further strengthen financial position.
Financial highlights
Group revenue reached €1.59 billion, up 3% year-over-year; adjusted EBITDA was €408 million, up 6%, with a 26% margin, up 0.9 percentage points.
Net profit for the year was €90 million, an increase of €126 million year-over-year.
Sale of Ansan plant contributed €325 million to EBITDA and EBIT, €247 million to net income, and €6.37 to EPS.
Cash and equivalents plus unused credit lines totaled €741 million, with an additional €100 million deposit recently made available.
Net debt/EBITDA at 2.5x; equity ratio increased to 23.3%.
Outlook and guidance
Q1 2025–2026 revenue guidance is approximately €400 million, up 14% year-over-year, with EBITDA margin expected at 16% due to ramp-up costs; net CAPEX around €60–65 million.
Full-year guidance withheld due to market uncertainty, including U.S. tariffs and potential recession risks; midterm guidance remains unchanged with revenue targeted at €2.1–2.4 billion and EBITDA margin 24–28%.
Planned Q1 investments of €65 million, with slightly higher quarterly numbers expected by year-end.
Latest events from AT & S Austria Technologie & Systemtechnik
- Revenue up 10% to €1.314B, EBITDA margin 23%, strong outlook despite FX and supply risks.ATS
Q3 20263 Feb 2026 - Adjusted EBITDA margin rose to 27.6% despite revenue decline and net loss.ATS
Q1 20252 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue, EBITDA, and cash flow improved, but FX and supply chain risks persist.ATS
Q2 202616 Dec 2025 - Revenue up 14.2% year-over-year, but net loss widened on FX and ramp-up costs.ATS
Q1 202616 Nov 2025 - Revenue and earnings fell amid price pressure, but mid-term growth targets are reaffirmed.ATS
Q2 202513 Jun 2025